4.7 Article

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Mesenchymal stem/stromal cells in cancer therapy

Tianxia Lan et al.

Summary: Multipotent mesenchymal stem/stromal cells (MSCs) have been identified in almost all tissues of the human body, showing potential in cancer treatment due to their multipotency, immunomodulation capacity, and tumor-homing property. However, controversial roles of MSCs in crosstalk with tumors hinder translational medicine progress.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Review Oncology

Challenges and advances in clinical applications of mesenchymal stromal cells

Tian Zhou et al.

Summary: MSC therapy for clinical applications faces challenges due to inconsistent criteria for MSCs identity and their inherited heterogeneity. Strategies have been developed to overcome these challenges with the emergence of advanced biological techniques and substantial improvements in bio-engineered materials.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Oncology

Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Arnon Nagler et al.

Summary: In this study comparing haploidentical stem cell transplantation (HaploSCT) and matched sibling donor (MSD) transplantation in adult patients with acute lymphoblastic leukemia (ALL) in complete remission (CR), the outcomes in terms of leukemia-free survival, overall survival, and GVHD-free, relapse-free survival were found to be comparable between the two transplant groups.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Review Oncology

Roles of the intestinal microbiota and microbial metabolites in acute GVHD

Dandan Lin et al.

Summary: The intestinal microbiota plays a crucial role in the pathogenesis of acute GVHD, with dysbiosis associated with poor prognosis. Intervention strategies targeting the microbiota, such as antibiotics, prebiotics, probiotics, postbiotics, and fecal microbiota transplantation, are potential new treatment options for acute GVHD.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

Article Oncology

Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT

Jaime Sanz et al.

Summary: In allogeneic hematopoietic stem cell transplantation using PTCy for GVHD prophylaxis in acute lymphoblastic leukemia patients, the donor type did not significantly impact transplant outcomes, with similar overall survival and relapse rates observed across different donor types.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Review Oncology

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

Xiao-hui Zhang et al.

Summary: The recent updated consensus recommendations from The Chinese Society of Hematology on allogeneic hematopoietic stem cell transplantation (allo-HSCT) include a new donor selection algorithm, encouraging salvage treatment with novel immunotherapies, and reflecting additional evidence for specific patient groups in transplantation application.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Multidisciplinary Sciences

Optimizing antithymocyte globulin dosing in haploidentical hematopoietic cell transplantation: long-term follow-up of a multicenter, randomized controlled trial

Yu Wang et al.

Summary: Randomized trial results indicate that a dosage of 7.5 mg/kg of ATG is more beneficial compared to 10 mg/kg in haplo-HCT patients, providing a better balance between GVHD and infection control.

SCIENCE BULLETIN (2021)

Article Medicine, General & Internal

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

Robert Zeiser et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Cell & Tissue Engineering

The Reparative Effects of Human Adipose-Derived Mesenchymal Stem Cells in the Chemotherapy-Damaged Thymus

Ying Zhan et al.

STEM CELLS AND DEVELOPMENT (2019)

Review Immunology

Remestemcel-L for the treatment of graft versus host disease

F. Locatelli et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)

Review Medicine, General & Internal

Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy

Robert Zeiser et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Multidisciplinary Sciences

Guanylate-binding protein 1 (GBP1) contributes to the immunity of human mesenchymal stromal cells against Toxoplasma gondii

Aiping Qin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Mathematical & Computational Biology

Practical recommendations for reporting Fine-Gray model analyses for competing risk data

Peter C. Austin et al.

STATISTICS IN MEDICINE (2017)

Article Hematology

Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients

Martino Introna et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)

Review Cell & Tissue Engineering

Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation

Maria Ester Bernardo et al.

CELL STEM CELL (2013)

Review Hematology

Secondary Treatment of Acute Graft-versus-Host Disease: A Critical Review

Paul J. Martin et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)

Letter Hematology

Diagnosis and management of acute graft-versus-host disease

Fiona L. Dignan et al.

BRITISH JOURNAL OF HAEMATOLOGY (2012)

Article Biophysics

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

J. Y. Weng et al.

BONE MARROW TRANSPLANTATION (2010)

Article Hematology

Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease

Partow Kebriaei et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)

Review Immunology

Mesenchymal stem cells in health and disease

Antonio Uccelli et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Article Hematology

How I treat refractory acute GVHD

H. Joachim Deeg

Review Medicine, General & Internal

Medical progress: Hematopoietic stem-cell transplantation

EA Copelan

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Multidisciplinary Sciences

Pluripotency of mesenchymal stem cells derived from adult marrow

YH Jiang et al.

NATURE (2002)